advertisement
European Journal of Pharmacology 44
Showing records 1 to 25 | Display all abstracts in European Journal of Pharmacology67538 Autoimmune aspects in glaucoma
von Thun Und Hohenstein-Blaul N
European Journal of Pharmacology 2016; 787: 105-118
67537 Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
Osborne NN
European Journal of Pharmacology 2016; 787: 127-133
67309 Targeting the complement system for the management of retinal inflammatory and degenerative diseases
Xu H
European Journal of Pharmacology 2016; 787: 94-104
67506 The exit strategy: Pharmacological modulation of extracellular matrix production and deposition for better aqueous humor drainage
Pattabiraman PP
European Journal of Pharmacology 2016; 787: 32-42
67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Russo R
European Journal of Pharmacology 2016; 787: 134-142
67308 Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: Pitfalls, promises and what lies ahead?
Prasanna G
European Journal of Pharmacology 2016; 787: 47-56
67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Nucci C
European Journal of Pharmacology 2016; 787: 119-126
66719 Paclitaxel inhibits cell proliferation and collagen lattice contraction via TGF-β signaling pathway in human tenon's fibroblasts in vitro
Chen N
European Journal of Pharmacology 2016; 777: 33-40
67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Li G
European Journal of Pharmacology 2016; 787: 20-31
67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Varano GP
European Journal of Pharmacology 2016; 787: 134-142
67309 Targeting the complement system for the management of retinal inflammatory and degenerative diseases
Chen M
European Journal of Pharmacology 2016; 787: 94-104
66719 Paclitaxel inhibits cell proliferation and collagen lattice contraction via TGF-β signaling pathway in human tenon's fibroblasts in vitro
Guo D
European Journal of Pharmacology 2016; 777: 33-40
67538 Autoimmune aspects in glaucoma
Bell K
European Journal of Pharmacology 2016; 787: 105-118
67308 Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: Pitfalls, promises and what lies ahead?
Li B
European Journal of Pharmacology 2016; 787: 47-56
67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Russo R
European Journal of Pharmacology 2016; 787: 119-126
67537 Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
Núñez-Álvarez C
European Journal of Pharmacology 2016; 787: 127-133
67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Mukherjee D
European Journal of Pharmacology 2016; 787: 20-31
67506 The exit strategy: Pharmacological modulation of extracellular matrix production and deposition for better aqueous humor drainage
Toris CB
European Journal of Pharmacology 2016; 787: 32-42
67537 Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
Joglar B
European Journal of Pharmacology 2016; 787: 127-133
67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Adornetto A
European Journal of Pharmacology 2016; 787: 134-142
67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Navarro I
European Journal of Pharmacology 2016; 787: 20-31
67538 Autoimmune aspects in glaucoma
Pfeiffer N
European Journal of Pharmacology 2016; 787: 105-118
67308 Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: Pitfalls, promises and what lies ahead?
Mogi M
European Journal of Pharmacology 2016; 787: 47-56
66719 Paclitaxel inhibits cell proliferation and collagen lattice contraction via TGF-β signaling pathway in human tenon's fibroblasts in vitro
Guo Y
European Journal of Pharmacology 2016; 777: 33-40
67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Martucci A
European Journal of Pharmacology 2016; 787: 119-126
